Skip to main content
Clinical Trials/CTRI/2019/07/020185
CTRI/2019/07/020185Active, not recruitingPhase 4

Dienogest versus GnRH-agonist (Leuprolide) prior to in-vitro-fertilization (IVF) cycle in women with endometriosis associated infertility: a randomized controlled study

Institute0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Active, not recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1)Endometriosis planned for IVF
  • 2)Diagnosed endometriosis at laparoscopy and or USG
  • 3)FSH <= 12 IU/L, AMH >= 1.5 ng/ml
  • 4)Willing to participate in the study

Exclusion Criteria

  • 1)Recurrent endometrioma
  • 2)Prior surgery on ovary including endometrioma drainage /cystectomy
  • 3)BMI > 30 kg/m2
  • 4)Uterine factor unfavorable for implantation (adenomyosis, intrauterine adhesions, thin endometrium, submucous fibroids)

Investigators

Sponsor
Institute

Similar Trials